Mesothelioma Research Programme Leicester
  • HOME
  • ABOUT US
    • RESEARCH TEAM
    • RESEARCH FUNDING
    • INDUSTRIAL PARTNERS
    • COLLABORATING INSTITUTIONS
    • USEFUL LINKS
  • WHAT WE DO
    • CLINICAL TRIALS
      • INDUSTRY TRIALS
        • ATOMIC
      • INVESTIGATOR LED STUDIES
        • MARS2
        • VIM
        • CONFIRM
        • FAK PD1 PHASE 1
        • MiST
        • MEDUSA
        • PEACE
    • TRANSLATIONAL RESEARCH
      • MESOTHELIOMA EVOLUTION
      • SPINDLE POISON PHARMACODYNAMICS
      • TARGETING CDKN2A-MTAP
      • MESOTHELIOMA STRATIFIED THERAPY (MiST)
  • PUBLICATIONS
    • SCIENTIFIC PAPERS
    • NEWS
  • CONTACT
    • DONATE
    • FOR HEALTH PROFESSIONALS
    • FOR PATIENTS
    • INDUSTRY
    • CAREER OPPORTUNITIES
    • PRIVACY POLICY
Select Page

The goal of the Leicester Mesothelioma Programme is to improve clinical outcomes for patients with malignant mesothelioma by translating new scientific advances in biology, through local, national and international collaborations, with academic, charitable, and industrial sectors.

Translational Research
Translational Research
Translational Research
Translational Research
Translational Research
Translational Research
Clinical Trials
Clinical Trials
Clinical Trials
Mesothelioma Research Programme Leicester University of Leicester University Hospitals of Leicester Leicester Precision Medicine Institute
Website Designed and Developed
by
Hyphen and Sandstar